GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » icad Inc (NAS:ICAD) » Definitions » Cyclically Adjusted PB Ratio

icad (ICAD) Cyclically Adjusted PB Ratio : 0.91 (As of May. 17, 2024)


View and export this data going back to 1992. Start your Free Trial

What is icad Cyclically Adjusted PB Ratio?

As of today (2024-05-17), icad's current share price is $1.8004. icad's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $1.97. icad's Cyclically Adjusted PB Ratio for today is 0.91.

The historical rank and industry rank for icad's Cyclically Adjusted PB Ratio or its related term are showing as below:

ICAD' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.54   Med: 1.09   Max: 8.76
Current: 0.9

During the past years, icad's highest Cyclically Adjusted PB Ratio was 8.76. The lowest was 0.54. And the median was 1.09.

ICAD's Cyclically Adjusted PB Ratio is ranked better than
78.8% of 467 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs ICAD: 0.90

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

icad's adjusted book value per share data for the three months ended in Dec. 2023 was $1.268. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.97 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


icad Cyclically Adjusted PB Ratio Historical Data

The historical data trend for icad's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

icad Cyclically Adjusted PB Ratio Chart

icad Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.54 5.56 3.34 0.88 0.90

icad Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.88 0.60 0.80 1.05 0.90

Competitive Comparison of icad's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, icad's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


icad's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, icad's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where icad's Cyclically Adjusted PB Ratio falls into.



icad Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

icad's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.8004/1.97
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

icad's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, icad's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.268/129.4194*129.4194
=1.268

Current CPI (Dec. 2023) = 129.4194.

icad Quarterly Data

Book Value per Share CPI Adj_Book
201403 3.626 99.695 4.707
201406 3.721 100.560 4.789
201409 4.024 100.428 5.186
201412 4.038 99.070 5.275
201503 3.934 99.621 5.111
201506 2.191 100.684 2.816
201509 2.199 100.392 2.835
201512 2.081 99.792 2.699
201603 1.939 100.470 2.498
201606 1.868 101.688 2.377
201609 1.732 101.861 2.201
201612 1.558 101.863 1.979
201703 1.579 102.862 1.987
201706 1.489 103.349 1.865
201709 1.095 104.136 1.361
201712 0.864 104.011 1.075
201803 0.686 105.290 0.843
201806 0.647 106.317 0.788
201809 0.584 106.507 0.710
201812 0.409 105.998 0.499
201903 0.264 107.251 0.319
201906 0.566 108.070 0.678
201909 0.424 108.329 0.507
201912 0.262 108.420 0.313
202003 0.710 108.902 0.844
202006 1.158 108.767 1.378
202009 1.103 109.815 1.300
202012 1.298 109.897 1.529
202103 2.138 111.754 2.476
202106 2.039 114.631 2.302
202109 1.985 115.734 2.220
202112 1.850 117.630 2.035
202203 1.738 121.301 1.854
202206 1.627 125.017 1.684
202209 1.492 125.227 1.542
202212 1.382 125.222 1.428
202303 1.255 127.348 1.275
202306 1.195 128.729 1.201
202309 1.182 129.860 1.178
202312 1.268 129.419 1.268

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


icad  (NAS:ICAD) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


icad Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of icad's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


icad (ICAD) Business Description

Traded in Other Exchanges
N/A
Address
98 Spit Brook Road, Suite 100, Nashua, NH, USA, 03062
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company reports in two segments: Detection and Therapy. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. In the Therapy segment, the Company offers the Xoft System, an isotope-free cancer treatment platform technology. The Xoft System can be used for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.
Executives
Eric Lonnqvist officer: See Remarks 98 SPIT BROOK ROAD, SUITE 100, NASHUA NH 02062
Daniel Joseph Shea officer: See Remarks 2 MINUTEMAN ROAD, MEDFIELD MA 02052
Jonathan Go officer: Sr. VP of R&D C/O ICAD, INC., 98 SPIT BROOK ROAD, SUITE 100, NASHUA NH 03062
Stephen P Sarno officer: See Remarks C/O SAPIENT CORPORATION, 25 FIRST STREET, CAMBRIDGE MA 02141
Andy Sassine director 82 DEVONSHIRE STREET, BOSTON MA 02109
Dana R Brown director 98 SPIT BROOK ROAD, SUITE 100, NASHUA NH 03062
Timothy Norris Irish director 98 SPIT BROOK ROAD, SUITE 100, NASHUA NH 03062
Nathaniel Dalton director C/O AFFILIATED MANAGERS GROUP INC, 777 S. FLAGLER DR., SUITE 1201 E. TOWER, WEST PALM BEACH FL 33401
Susan Alyson Wood director 845 MORENO AVENUE, PALO ALTO CA 94303
Michael S Klein director C/O ICAD INC, 98 SPIT BROOK ROAD SUITE 100, NASHUA NH 03062
Charles Ross Carter officer: See Remarks C/O GI DYNAMICS, INC., 745 ATLANTIC AVENUE, BOSTON MA 02111
Stacey M Stevens officer: Executive VP of Marketing C/O ICAD, INC., 98 SPIT BROOK ROAD, SUITE 100, NASHUA NH 03062
R. Scott Areglado officer: Interim Chief FinancialOfficer 98 SPIT BROOK ROAD, SUITE 100, C/O ICAD, INC., NASHUA NH 03062
Rakesh Patel director 15400 NATIONAL AVENUE, LOS GATOS CA 95032
Dr Lawrence Howard director C/O PRESSTEK INC, 2 GREENWICH OFFICE PARK, GREENWICH CT 06831